Literature DB >> 24462774

Dissociated presenilin-1 and TACE processing of ErbB4 in lung alveolar type II cell differentiation.

Najla Fiaturi1, Anika Ritzkat2, Christiane E L Dammann3, John J Castellot4, Heber C Nielsen5.   

Abstract

Neuregulin (NRG) stimulation of ErbB4 signaling is important for type II cell surfactant synthesis. ErbB4 may mediate gene expression via a non-canonical pathway involving enzymatic cleavage releasing its intracellular domain (4ICD) for nuclear trafficking and gene regulation. The accepted model for release of 4ICD is consecutive cleavage by Tumor necrosis factor alpha Converting Enzyme (TACE) and γ-secretase enzymes. Here, we show that 4ICD mediates surfactant synthesis and its release by γ-secretase is not dependent on previous TACE cleavage. We used siRNA to silence Presenilin-1 (PSEN-1) expression in a mouse lung type II epithelial cell line (MLE12 cells), and both siRNA knockdown and chemical inhibition of TACE. Knockdown of PSEN-1 significantly decreased baseline and NRG-stimulated surfactant phospholipid synthesis, expression of the surfactant proteins SP-B and SP-C, as well as 4ICD levels, with no change in ErbB4 ectodomain shedding. Neither siRNA knockdown nor chemical inhibition of TACE inhibited 4ICD release or surfactant synthesis. PSEN-1 cleavage of ErbB4 for non-canonical signaling through 4ICD release does not require prior cleavage by TACE.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ErbB receptor; Gamma secretase; Neonatal lung; Presenilin-1; Surfactant protein; Type II cell

Mesh:

Substances:

Year:  2014        PMID: 24462774      PMCID: PMC3953239          DOI: 10.1016/j.bbamcr.2014.01.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

1.  Surface properties in relation to atelectasis and hyaline membrane disease.

Authors:  M E AVERY; J MEAD
Journal:  AMA J Dis Child       Date:  1959-05

2.  Static volume-pressure relations of excised lungs of infants with hyaline membrane disease, newborn and stillborn infants.

Authors:  I GRIBETZ; N R FRANK; M E AVERY
Journal:  J Clin Invest       Date:  1959-12       Impact factor: 14.808

3.  Presenilin-1 and presenilin-2 exhibit distinct yet overlapping gamma-secretase activities.

Authors:  Ming-Tain Lai; Elizabeth Chen; Ming-Chih Crouthamel; Jillian DiMuzio-Mower; Min Xu; Qian Huang; Eric Price; R Bruce Register; Xiao-Ping Shi; Dorit B Donoviel; Alan Bernstein; Daria Hazuda; Stephen J Gardell; Yue-Ming Li
Journal:  J Biol Chem       Date:  2003-04-08       Impact factor: 5.157

4.  Dissociated phenotypes in presenilin transgenic mice define functionally distinct gamma-secretases.

Authors:  Peter Mastrangelo; Paul M Mathews; M Azhar Chishti; Stephen D Schmidt; Yongjun Gu; Jing Yang; Matthew J Mazzella; Janaky Coomaraswamy; Patrick Horne; Bob Strome; Heather Pelly; Georges Levesque; Chris Ebeling; Ying Jiang; Ralph A Nixon; Richard Rozmahel; Paul E Fraser; Peter St George-Hyslop; George A Carlson; David Westaway
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-10       Impact factor: 11.205

5.  Compliance of the respiratory system in newborn infants pre- and postsurfactant replacement therapy.

Authors:  E Kelly; H Bryan; F Possmayer; H Frndova; C Bryan
Journal:  Pediatr Pulmonol       Date:  1993-04

Review 6.  Surfactant metabolism.

Authors:  A H Jobe; M Ikegami
Journal:  Clin Perinatol       Date:  1993-12       Impact factor: 3.430

7.  Role of neuregulin-1 beta in the developing lung.

Authors:  Christiane E L Dammann; Heber C Nielsen; Kermit L Carraway
Journal:  Am J Respir Crit Care Med       Date:  2003-03-27       Impact factor: 21.405

8.  Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency.

Authors:  A Herreman; D Hartmann; W Annaert; P Saftig; K Craessaerts; L Serneels; L Umans; V Schrijvers; F Checler; H Vanderstichele; V Baekelandt; R Dressel; P Cupers; D Huylebroeck; A Zwijsen; F Van Leuven; B De Strooper
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

9.  Stimulation of phosphatidylcholine biosynthesis in mouse MLE-12 type-II cells by conditioned medium from cortisol-treated rat fetal lung fibroblasts.

Authors:  J I MacDonald; F Possmayer
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

10.  Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism.

Authors:  M Vecchi; G Carpenter
Journal:  J Cell Biol       Date:  1997-11-17       Impact factor: 10.539

View more
  6 in total

1.  Interdependent TTF1 - ErbB4 interactions are critical for surfactant protein-B homeostasis in primary mouse lung alveolar type II cells.

Authors:  Elger Marten; Heber C Nielsen; Christiane E L Dammann
Journal:  J Cell Commun Signal       Date:  2015-07-22       Impact factor: 5.782

2.  Neuregulin-ErbB4 signaling in the developing lung alveolus: a brief review.

Authors:  Najla Fiaturi; John J Castellot; Heber C Nielsen
Journal:  J Cell Commun Signal       Date:  2014-05-31       Impact factor: 5.782

3.  Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake.

Authors:  Jonathan W Haskins; Shannon Zhang; Robert E Means; Joanne K Kelleher; Gary W Cline; Alberto Canfrán-Duque; Yajaira Suárez; David F Stern
Journal:  Sci Signal       Date:  2015-11-03       Impact factor: 8.192

4.  ErbB4 alternative splicing mediates fetal mouse alveolar type II cell differentiation in vitro.

Authors:  Christiane E L Dammann; Heber C Nielsen; Dorothea Wiegel
Journal:  Pediatr Res       Date:  2022-03-25       Impact factor: 3.953

5.  HER2+ Cancer Cell Dependence on PI3K vs. MAPK Signaling Axes Is Determined by Expression of EGFR, ERBB3 and CDKN1B.

Authors:  Daniel C Kirouac; Jinyan Du; Johanna Lahdenranta; Matthew D Onsum; Ulrik B Nielsen; Birgit Schoeberl; Charlotte F McDonagh
Journal:  PLoS Comput Biol       Date:  2016-04-01       Impact factor: 4.475

Review 6.  What is the identity of fibroblast-pneumocyte factor?

Authors:  George King; Megan E Smith; Max H Cake; Heber C Nielsen
Journal:  Pediatr Res       Date:  2016-08-08       Impact factor: 3.756

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.